{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T18:08:16Z","timestamp":1792001296353,"version":"4.4.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,6]],"date-time":"2023-08-06T00:00:00Z","timestamp":1691280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,6]],"date-time":"2023-08-06T00:00:00Z","timestamp":1691280000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Enterococcal bacteremia has become prevalent in the recent decade, especially in hospitalized patients. Moreover, the rise in resistance patterns against antibiotic drugs regarding enterococci infection, such as cephalosporins, ampicillin and vancomycin, is prevailing. The major driving force behind this is the incongruous use of antibiotics with a minor contribution from environmental stressors which calls for vigilant and prudent administration of evidence-based antibiotics.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A retrospective study was conducted from January 1 2017 until December 31 2021, at the tertiary care center, Dr Ziauddin Hospital in Karachi, Pakistan.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Our research revealed ampicillin resistance in 87 (63.5%), with an estimated 25 (18.8%) mortality. Male gender 19 (76%) and vancomycin resistance 13 (52%) were associated with increased mortality. Furthermore, appropriate antibiotic therapy reduced the risk of death compared with inappropriate and excessive use of antibiotics 10 (40%) vs. 15 (60%) vs. 20 (80%) respectively. Targeted therapy with amoxicillin\/clavulanic acid was associated with lower mortality 1 (4%) and higher discharge rates 34 (32.1%). On Kaplan-Meier survival, targeted therapy with amoxicillin\/clavulanic acid was associated with shorter hospital stays and prolonged survival. UTI was found as the most common source of enterococcal bacteremia 57 (41.6%), followed by respiratory 21 (15.3%) and intra-abdominal 13 (9.5%). In 26 (19%) patients, no identifiable source of infection was found.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Vancomycin resistance and male gender were found independent risk factors for mortality. The use of inappropriate antibiotics significantly increases mortality in these patients. The appropriate antibiotic therapy reduces the risk of death. Furthermore, overuse of antibiotics didn\u2019t reduce mortality; instead increased the financial burden and chances of developing multi-drug resistant strains of other organisms by increasing hospital stays of patients.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12879-023-08498-0","type":"journal-article","created":{"date-parts":[[2023,8,6]],"date-time":"2023-08-06T19:01:45Z","timestamp":1691348505000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Antibiotic choices among healthcare professionals for enterococcal bacteremia with patterns of resistance and risk factors of mortality, in settings of poor antibiotic stewardship program \u2014 a five-year retrospective cohort study"],"prefix":"10.1186","volume":"23","author":[{"given":"Jamil Muqtadir","family":"Bhatti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed Ali","family":"Raza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayesha Farooq","family":"Alam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yameena Noman","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Mala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irshad","family":"Batool","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"FNU","family":"Sameeullah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,6]]},"reference":[{"issue":"4","key":"8498_CR1","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1128\/CMR.6.4.428","volume":"6","author":"TG Emori","year":"1993","unstructured":"Emori TG, Gaynes RP. An overview of nosocomial infections, including the role of the microbiology laboratory. Clin Microbiol Rev. 1993;6(4):428\u201342.","journal-title":"Clin Microbiol Rev"},{"issue":"2","key":"8498_CR2","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0732-8893(97)00115-6","volume":"29","author":"RN Jones","year":"1997","unstructured":"Jones RN, Marshall SA, Pfaller MA, Wilke WW, Hollis RJ, Erwin ME, et al. Nosocomial enterococcal blood stream infections in the SCOPE Program: antimicrobial resistance, species occurrence, molecular testing results, and laboratory testing accuracy. SCOPE Hospital Study Group. Diagn Microbiol Infect Dis. 1997;29(2):95\u2013102.","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"6","key":"8498_CR3","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1093\/clinids\/14.6.1173","volume":"14","author":"RC Moellering","year":"1992","unstructured":"Moellering RC. Jr. Emergence of Enterococcus as a significant pathogen. Clin Infect Dis. 1992;14(6):1173\u20136.","journal-title":"Clin Infect Dis"},{"issue":"7","key":"8498_CR4","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1128\/AAC.42.7.1762","volume":"42","author":"MA Pfaller","year":"1998","unstructured":"Pfaller MA, Jones RN, Doern GV, Kugler K. Bacterial pathogens isolated from patients with bloodstream infection: frequencies of occurrence and antimicrobial susceptibility patterns from the SENTRY antimicrobial surveillance program (United States and Canada, 1997). Antimicrob Agents Chemother. 1998;42(7):1762\u201370.","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl 2","key":"8498_CR5","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1086\/320185","volume":"32","author":"DE Low","year":"2001","unstructured":"Low DE, Keller N, Barth A, Jones RN. Clinical prevalence, antimicrobial susceptibility, and geographic resistance patterns of enterococci: results from the SENTRY Antimicrobial Surveillance Program, 1997\u20131999. Clin Infect Dis. 2001;32(Suppl 2):133\u201345.","journal-title":"Clin Infect Dis"},{"issue":"10","key":"8498_CR6","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1056\/NEJM200003093421007","volume":"342","author":"BE Murray","year":"2000","unstructured":"Murray BE. Vancomycin-resistant enterococcal infections. N Engl J Med. 2000;342(10):710\u201321.","journal-title":"N Engl J Med"},{"issue":"2","key":"8498_CR7","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1093\/clinids\/20.2.296","volume":"20","author":"GA Noskin","year":"1995","unstructured":"Noskin GA, Peterson LR, Warren JR. Enterococcus faecium and Enterococcus faecalis bacteremia: acquisition and outcome. Clin Infect Dis. 1995;20(2):296\u2013301.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"8498_CR8","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/00005792-199507000-00003","volume":"74","author":"JE Patterson","year":"1995","unstructured":"Patterson JE, Sweeney AH, Simms M, Carley N, Mangi R, Sabetta J, et al. An analysis of 110 serious enterococcal infections. Epidemiology, antibiotic susceptibility, and outcome. Med (Baltim). 1995;74(4):191\u2013200.","journal-title":"Med (Baltim)"},{"issue":"3","key":"8498_CR9","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1086\/430909","volume":"41","author":"CA DiazGranados","year":"2005","unstructured":"DiazGranados CA, Zimmer SM, Klein M, Jernigan JA. Comparison of mortality associated with vancomycin-resistant and vancomycin-susceptible enterococcal bloodstream infections: a meta-analysis. Clin Infect Dis. 2005;41(3):327\u201333.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"8498_CR10","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1086\/318717","volume":"32","author":"FJ Caballero-Granado","year":"2001","unstructured":"Caballero-Granado FJ, Becerril B, Cuberos L, Bernabeu M, Cisneros JM, Pach\u00f3n J. Attributable mortality rate and duration of hospital stay associated with enterococcal bacteremia. Clin Infect Dis. 2001;32(4):587\u201394.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"8498_CR11","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1093\/clinids\/20.5.1126","volume":"20","author":"MB Edmond","year":"1995","unstructured":"Edmond MB, Ober JF, Weinbaum DL, Pfaller MA, Hwang T, Sanford MD, et al. Vancomycin-resistant Enterococcus faecium bacteremia: risk factors for infection. Clin Infect Dis. 1995;20(5):1126\u201333.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"8498_CR12","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1093\/clinids\/22.4.663","volume":"22","author":"PK Linden","year":"1996","unstructured":"Linden PK, Pasculle AW, Manez R, Kramer DJ, Fung JJ, Pinna AD, et al. Differences in outcomes for patients with bacteremia due to vancomycin-resistant Enterococcus faecium or vancomycin-susceptible E. faecium. Clin Infect Dis. 1996;22(4):663\u201370.","journal-title":"Clin Infect Dis"},{"issue":"Suppl 1","key":"8498_CR13","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/S0163-4453(09)60003-7","volume":"59","author":"N Woodford","year":"2009","unstructured":"Woodford N, Livermore DM. Infections caused by Gram-positive bacteria: a review of the global challenge. J Infect. 2009;59(Suppl 1):4\u201316.","journal-title":"J Infect"},{"issue":"1","key":"8498_CR14","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s10096-009-0830-5","volume":"29","author":"SJ McBride","year":"2010","unstructured":"McBride SJ, Upton A, Roberts SA. Clinical characteristics and outcomes of patients with vancomycin-susceptible Enterococcus faecalis and Enterococcus faecium bacteraemia\u2013a five-year retrospective review. Eur J Clin Microbiol Infect Dis. 2010;29(1):107\u201314.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"7","key":"8498_CR15","doi-asserted-by":"crossref","first-page":"484","DOI":"10.7326\/0003-4819-135-7-200110020-00007","volume":"135","author":"EN Vergis","year":"2001","unstructured":"Vergis EN, Hayden MK, Chow JW, Snydman DR, Zervos MJ, Linden PK, et al. Determinants of vancomycin resistance and mortality rates in enterococcal bacteremia. A prospective multicenter study. Ann Intern Med. 2001;135(7):484\u201392.","journal-title":"Ann Intern Med"},{"issue":"9","key":"8498_CR16","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.amjmed.2010.03.021","volume":"123","author":"BC Pien","year":"2010","unstructured":"Pien BC, Sundaram P, Raoof N, Costa SF, Mirrett S, Woods CW, et al. The clinical and prognostic importance of positive blood cultures in adults. Am J Med. 2010;123(9):819\u201328.","journal-title":"Am J Med"},{"issue":"2","key":"8498_CR17","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/BF01963635","volume":"9","author":"CM Lewis","year":"1990","unstructured":"Lewis CM, Zervos MJ. Clinical manifestations of enterococcal infection. Eur J Clin Microbiol Infect Dis. 1990;9(2):111\u20137.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"2","key":"8498_CR18","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/00000658-199008000-00007","volume":"212","author":"PS Barie","year":"1990","unstructured":"Barie PS, Christou NV, Dellinger EP, Rout WR, Stone HH, Waymack JP. Pathogenicity of the enterococcus in surgical infections. Ann Surg. 1990;212(2):155\u20139.","journal-title":"Ann Surg"},{"issue":"4","key":"8498_CR19","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1093\/clinids\/13.4.600","volume":"13","author":"CW Hoge","year":"1991","unstructured":"Hoge CW, Adams J, Buchanan B, Sears SD. Enterococcal bacteremia: to treat or not to treat, a reappraisal. Rev Infect Dis. 1991;13(4):600\u20135.","journal-title":"Rev Infect Dis"},{"issue":"1","key":"8498_CR20","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/00000658-198207000-00010","volume":"196","author":"RN Garrison","year":"1982","unstructured":"Garrison RN, Fry DE, Berberich S, Polk HC. Jr. Enterococcal bacteremia: clinical implications and determinants of death. Ann Surg. 1982;196(1):43\u20137.","journal-title":"Ann Surg"},{"issue":"3","key":"8498_CR21","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0195-6701(94)90125-2","volume":"27","author":"J Gray","year":"1994","unstructured":"Gray J, Marsh PJ, Stewart D, Pedler SJ. Enterococcal bacteraemia: a prospective study of 125 episodes. J Hosp Infect. 1994;27(3):179\u201386.","journal-title":"J Hosp Infect"},{"issue":"1","key":"8498_CR22","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/clinids\/15.1.49","volume":"15","author":"W Graninger","year":"1992","unstructured":"Graninger W, Ragette R. Nosocomial bacteremia due to Enterococcus faecalis without endocarditis. Clin Infect Dis. 1992;15(1):49\u201357.","journal-title":"Clin Infect Dis"},{"issue":"11","key":"8498_CR23","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.2337\/diacare.26.11.2977","volume":"26","author":"DJ Cuff","year":"2003","unstructured":"Cuff DJ, Meneilly GS, Martin A, Ignaszewski A, Tildesley HD, Frohlich JJ. Effective exercise modality to reduce insulin resistance in women with type 2 diabetes. Diabetes Care. 2003;26(11):2977\u201382.","journal-title":"Diabetes Care"},{"issue":"5","key":"8498_CR24","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1046\/j.1365-2796.1998.00379.x","volume":"244","author":"L Leibovici","year":"1998","unstructured":"Leibovici L, Shraga I, Drucker M, Konigsberger H, Samra Z, Pitlik SD. The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection. J Intern Med. 1998;244(5):379\u201386.","journal-title":"J Intern Med"},{"issue":"6","key":"8498_CR25","first-page":"557","volume":"160","author":"CS Bryan","year":"1985","unstructured":"Bryan CS, Reynolds KL, Brown JJ. Mortality associated with enterococcal bacteremia. Surg Gynecol Obstet. 1985;160(6):557\u201361.","journal-title":"Surg Gynecol Obstet"},{"issue":"5","key":"8498_CR26","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1086\/501624","volume":"20","author":"E Lautenbach","year":"1999","unstructured":"Lautenbach E, Bilker WB, Brennan PJ. Enterococcal bacteremia: risk factors for vancomycin resistance and predictors of mortality. Infect Control Hosp Epidemiol. 1999;20(5):318\u201323.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"5","key":"8498_CR27","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1086\/341977","volume":"35","author":"EN Vergis","year":"2002","unstructured":"Vergis EN, Shankar N, Chow JW, Hayden MK, Snydman DR, Zervos MJ, et al. Association between the presence of enterococcal virulence factors gelatinase, hemolysin, and enterococcal surface protein and mortality among patients with bacteremia due to Enterococcus faecalis. Clin Infect Dis. 2002;35(5):570\u20135.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"8498_CR28","doi-asserted-by":"crossref","first-page":"38","DOI":"10.4103\/0255-0857.174099","volume":"34","author":"A Tripathi","year":"2016","unstructured":"Tripathi A, Shukla SK, Singh A, Prasad KN. Prevalence, outcome and risk factor associated with vancomycin-resistant Enterococcus faecalis and Enterococcus faecium at a Tertiary Care Hospital in Northern India. Indian J Med Microbiol. 2016;34(1):38\u201345.","journal-title":"Indian J Med Microbiol"},{"issue":"12","key":"8498_CR29","doi-asserted-by":"crossref","first-page":"e0021321","DOI":"10.1128\/JCM.00213-21","volume":"59","author":"R Humphries","year":"2021","unstructured":"Humphries R, Bobenchik AM, Hindler JA, Schuetz AN. Overview of changes to the Clinical and Laboratory Standards Institute Performance Standards for Antimicrobial susceptibility testing, M100, 31st Edition. J Clin Microbiol. 2021;59(12):e0021321.","journal-title":"J Clin Microbiol"},{"issue":"3","key":"8498_CR30","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1086\/313694","volume":"30","author":"JM Garbutt","year":"2000","unstructured":"Garbutt JM, Ventrapragada M, Littenberg B, Mundy LM. Association between resistance to vancomycin and death in cases of Enterococcus faecium bacteremia. Clin Infect Dis. 2000;30(3):466\u201372.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"8498_CR31","doi-asserted-by":"crossref","first-page":"220","DOI":"10.3904\/kjim.2011.26.2.220","volume":"26","author":"DG Lee","year":"2011","unstructured":"Lee DG, Kim SH, Kim SY, Kim CJ, Park WB, Song YG, et al. Evidence-based guidelines for empirical therapy of neutropenic fever in Korea. Korean J Intern Med. 2011;26(2):220\u201352.","journal-title":"Korean J Intern Med"},{"key":"8498_CR32","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jhin.2022.01.011","volume":"122","author":"Z Dai","year":"2022","unstructured":"Dai Z, Chen LY, Cai MJ, Yao YH, Zhu JH, Fang LL, et al. Clinical characteristics and microbiology of nosocomial enterococcal bloodstream infections in a tertiary-level hospital: a retrospective study, 2007\u20132019. J Hosp Infect. 2022;122:203\u201310.","journal-title":"J Hosp Infect"},{"issue":"1","key":"8498_CR33","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s13756-017-0231-y","volume":"6","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, Du M, Chang Y, Chen L-a, Zhang Q. Incidence, clinical characteristics, and outcomes of nosocomial Enterococcus spp. bloodstream infections in a tertiary-care hospital in Beijing, China: a four-year retrospective study. Antimicrob Resist Infect Control. 2017;6(1):73.","journal-title":"Antimicrob Resist Infect Control"},{"key":"8498_CR34","doi-asserted-by":"crossref","unstructured":"Mancuso G, Midiri A, Gerace E, Biondo C. Bacterial antibiotic resistance: the most critical pathogens. Pathogens. 2021;10(10).","DOI":"10.3390\/pathogens10101310"},{"key":"8498_CR35","doi-asserted-by":"crossref","unstructured":"Chatterjee A, Johnson CN, Luong P, Hullahalli K, McBride SW, Schubert AM et al. Bacteriophage resistance alters antibiotic-mediated intestinal expansion of Enterococci. Infect Immun. 2019;87(6).","DOI":"10.1128\/IAI.00085-19"},{"issue":"11","key":"8498_CR36","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.3855\/jidc.6587","volume":"9","author":"M Ceci","year":"2015","unstructured":"Ceci M, Delpech G, Sparo M, Mezzina V, S\u00e1nchez Bruni S, Baldaccini B. Clinical and microbiological features of bacteremia caused by Enterococcus faecalis. J Infect Developing Ctries. 2015;9(11):1195\u2013203.","journal-title":"J Infect Developing Ctries"},{"issue":"3","key":"8498_CR37","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0732-8893(00)00192-9","volume":"38","author":"RL Lark","year":"2000","unstructured":"Lark RL, Chenoweth C, Saint S, Zemencuk JK, Lipsky BA, Plorde JJ. Four year prospective evaluation of nosocomial bacteremia: epidemiology, microbiology, and patient outcome. Diagn Microbiol Infect Dis. 2000;38(3):131\u201340.","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"1","key":"8498_CR38","first-page":"10","volume":"44","author":"MJ Artico","year":"2012","unstructured":"Artico MJ, Rocchi M, Gasparotto A, Oca\u00f1a Carrizo V, Navarro M, Mollo V, et al. [Community-acquired bacteremia in adult patients attending the emergency service of a teaching hospital]. Rev Argent Microbiol. 2012;44(1):10\u20135.","journal-title":"Rev Argent Microbiol"},{"issue":"01","key":"8498_CR39","first-page":"25","volume":"2","author":"L Shah","year":"2012","unstructured":"Shah L, Mulla S, Patel KG, Rewadiwala S, PREVALENCE OF ENTEROCOCCI WITH HIGHER RESISTANCE. LEVEL IN A TERTIARY CARE HOSPITAL: A MATTER OF CONCERN. Natl J Med Res. 2012;2(01):25\u20137.","journal-title":"Natl J Med Res"},{"key":"8498_CR40","volume-title":"Enterococci: from commensals to leading causes of drug resistant infection","author":"CJ Kristich","year":"2014","unstructured":"Kristich CJ, Rice LB, Arias CA. Enterococcal infection\u2014treatment and antibiotic resistance. In: Gilmore MS, Clewell DB, Ike Y, Shankar N, editors. Enterococci: from commensals to leading causes of drug resistant infection. Boston: Massachusetts Eye and Ear Infirmary; 2014."},{"issue":"1","key":"8498_CR41","first-page":"27","volume":"24","author":"N Babar","year":"2014","unstructured":"Babar N, Usman J, Munir T, Gill MM, Anjum R, Gilani M, et al. Frequency and antibiogram of vancomycin resistant enterococcus in a tertiary care hospital. J Coll Physicians Surg Pak. 2014;24(1):27\u20139.","journal-title":"J Coll Physicians Surg Pak"},{"issue":"3","key":"8498_CR42","first-page":"286","volume":"22","author":"FE Abdulla","year":"2006","unstructured":"Abdulla FE, Abdulla EM. Antibiotic options for Enterococcus Faecalis Infections. Antibiotic options for Enterococcus Faecalis Infections. 2006;22(3):286\u201390.","journal-title":"Antibiotic Options for Enterococcus Faecalis Infections"},{"issue":"2","key":"8498_CR43","doi-asserted-by":"crossref","first-page":"394","DOI":"10.4103\/0976-9668.160018","volume":"6","author":"A Chakraborty","year":"2015","unstructured":"Chakraborty A, Pal NK, Sarkar S, Gupta MS. Antibiotic resistance pattern of Enterococci isolates from nosocomial infections in a tertiary care hospital in Eastern India. J Nat Sci Biol Med. 2015;6(2):394\u20137.","journal-title":"J Nat Sci Biol Med"},{"key":"8498_CR44","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.nmni.2018.08.018","volume":"26","author":"P Asadollahi","year":"2018","unstructured":"Asadollahi P, Razavi S, Asadollahi K, Pourshafie MR, Talebi M. Rise of antibiotic resistance in clinical enterococcal isolates during 2001\u20132016 in Iran: a review. New Microbes New Infect. 2018;26:92\u20139.","journal-title":"New Microbes New Infect"},{"issue":"2","key":"8498_CR45","doi-asserted-by":"crossref","first-page":"218","DOI":"10.3390\/antibiotics12020218","volume":"12","author":"F Napolitano","year":"2023","unstructured":"Napolitano F, Pelullo CP, Lamberti M, Donnarumma G, Di Giuseppe G. Antimicrobial Prescribing Practices in Hospital Settings in Italy: a retrospective study. Antibiotics. 2023;12(2):218.","journal-title":"Antibiotics"},{"issue":"4142","key":"8498_CR46","first-page":"w20135","volume":"149","author":"N G\u00fcrtler","year":"2019","unstructured":"G\u00fcrtler N, Erba A, Giehl C, Tschudin-Sutter S, Bassetti S, Osthoff M. Appropriateness of antimicrobial prescribing in a swiss tertiary care hospital: a repeated point prevalence survey. Swiss Med Wkly. 2019;149(4142):w20135\u2013w.","journal-title":"Swiss Med Wkly"},{"issue":"2","key":"8498_CR47","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1093\/jac\/dky447","volume":"74","author":"KJ Denny","year":"2019","unstructured":"Denny KJ, Gartside JG, Alcorn K, Cross JW, Maloney S, Keijzers G. Appropriateness of antibiotic prescribing in the emergency department. J Antimicrob Chemother. 2019;74(2):515\u201320.","journal-title":"J Antimicrob Chemother"},{"key":"8498_CR48","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1007\/s10096-015-2398-6","volume":"34","author":"H Akhloufi","year":"2015","unstructured":"Akhloufi H, Streefkerk R, Melles D, de Steenwinkel J, Schurink C, Verkooijen R, et al. Point prevalence of appropriate antimicrobial therapy in a dutch university hospital. Eur J Clin Microbiol Infect Dis. 2015;34:1631\u20137.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"6","key":"8498_CR49","doi-asserted-by":"crossref","first-page":"475","DOI":"10.3390\/life11060475","volume":"11","author":"M Macera","year":"2021","unstructured":"Macera M, Cal\u00f2 F, Onorato L, Di Caprio G, Monari C, Russo A, et al. Inappropriateness of antibiotic prescribing in medical, surgical and intensive care units: results of a multicentre observational study. Life. 2021;11(6):475.","journal-title":"Life"},{"key":"8498_CR50","doi-asserted-by":"crossref","unstructured":"Davey P, Brown E, Charani E, Fenelon L, Gould IM, Holmes A et al. Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane database of systematic reviews. 2013(4).","DOI":"10.1002\/14651858.CD003543.pub3"},{"issue":"3","key":"8498_CR51","first-page":"923","volume":"72","author":"CM van den Bosch","year":"2017","unstructured":"van den Bosch CM, Hulscher ME, Akkermans RP, Wille J, Geerlings SE, Prins JM. Appropriate antibiotic use reduces length of hospital stay. J Antimicrob Chemother. 2017;72(3):923\u201332.","journal-title":"J Antimicrob Chemother"},{"key":"8498_CR52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13756-019-0471-0","volume":"8","author":"D Nathwani","year":"2019","unstructured":"Nathwani D, Varghese D, Stephens J, Ansari W, Martin S, Charbonneau C. Value of hospital antimicrobial stewardship programs [ASPs]: a systematic review. Antimicrob Resist Infect Control. 2019;8:1\u201313.","journal-title":"Antimicrob Resist Infect Control"},{"issue":"8","key":"8498_CR53","doi-asserted-by":"crossref","first-page":"e026072","DOI":"10.1136\/bmjopen-2018-026072","volume":"9","author":"H Wang","year":"2019","unstructured":"Wang H, Wang H, Yu X, Zhou H, Li B, Chen G, et al. Impact of antimicrobial stewardship managed by clinical pharmacists on antibiotic use and drug resistance in a chinese hospital, 2010\u20132016: a retrospective observational study. BMJ open. 2019;9(8):e026072.","journal-title":"BMJ open"},{"issue":"1","key":"8498_CR54","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1186\/s12879-021-06043-5","volume":"21","author":"M Atif","year":"2021","unstructured":"Atif M, Ihsan B, Malik I, Ahmad N, Saleem Z, Sehar A, et al. Antibiotic stewardship program in Pakistan: a multicenter qualitative study exploring medical doctors\u2019 knowledge, perception and practices. BMC Infect Dis. 2021;21(1):374.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"8498_CR55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12875-017-0619-z","volume":"18","author":"LG Tillekeratne","year":"2017","unstructured":"Tillekeratne LG, Bodinayake CK, Dabrera T, Nagahawatte A, Arachchi WK, Sooriyaarachchi A, et al. Antibiotic overuse for acute respiratory tract infections in Sri Lanka: a qualitative study of outpatients and their physicians. BMC Fam Pract. 2017;18(1):1\u201310.","journal-title":"BMC Fam Pract"},{"issue":"10","key":"8498_CR56","doi-asserted-by":"crossref","first-page":"e012244","DOI":"10.1136\/bmjopen-2016-012244","volume":"6","author":"S Fletcher-Lartey","year":"2016","unstructured":"Fletcher-Lartey S, Yee M, Gaarslev C, Khan R. Why do general practitioners prescribe antibiotics for upper respiratory tract infections to meet patient expectations: a mixed methods study. BMJ Open. 2016;6(10):e012244.","journal-title":"BMJ Open"},{"issue":"7","key":"8498_CR57","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1111\/j.1469-0691.2010.03394.x","volume":"17","author":"M Suppli","year":"2011","unstructured":"Suppli M, Aabenhus R, Harboe ZB, Andersen LP, Tvede M, Jensen JUS. Mortality in enterococcal bloodstream infections increases with inappropriate antimicrobial therapy. Clin Microbiol Infect. 2011;17(7):1078\u201383.","journal-title":"Clin Microbiol Infect"},{"issue":"6","key":"8498_CR58","first-page":"457","volume":"170","author":"M Freundlich","year":"2008","unstructured":"Freundlich M, Thomsen RW, Pedersen L, West H, Sch\u00f8nheyder HC. Aminoglycosides therapy in patients with bacteraemia. Ugeskr Laeger. 2008;170(6):457\u201360.","journal-title":"Ugeskr Laeger"},{"issue":"6","key":"8498_CR59","first-page":"557","volume":"160","author":"C Bryan","year":"1985","unstructured":"Bryan C, Reynolds K, Brown J. Mortality associated with enterococcal bacteremia. Surg Gynecol Obstet. 1985;160(6):557\u201361.","journal-title":"Surg Gynecol Obstet"},{"issue":"9","key":"8498_CR60","doi-asserted-by":"crossref","first-page":"576","DOI":"10.2307\/30141943","volume":"17","author":"L Stroud","year":"1996","unstructured":"Stroud L, Edwards J, Danzing L, Culver D, Gaynes R. Risk factors for mortality associated with enterococcal bloodstream infections. Infect Control Hosp Epidemiol. 1996;17(9):576\u201380.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"4","key":"8498_CR61","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1093\/infdis\/172.4.993","volume":"172","author":"DK Shay","year":"1995","unstructured":"Shay DK, Maloney SA, Montecalvo M, Banerjee S, Wormser GP, Arduino MJ, et al. Epidemiology and mortality risk of vancomycin-resistant enterococcal bloodstream infections. J Infect Dis. 1995;172(4):993\u20131000.","journal-title":"J Infect Dis"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-023-08498-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-023-08498-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-023-08498-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T03:06:03Z","timestamp":1700622363000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-023-08498-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,6]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["8498"],"URL":"https:\/\/doi.org\/10.1186\/s12879-023-08498-0","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,6]]},"assertion":[{"value":"21 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experiments have been performed in accordance with the Declaration of Helsinki and the research has been approved by Dr. Ziauddin university ethical review committee on March 11, 2022. Written informed consent was waived by Dr. Ziauddin university ethical review committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"514"}}